Patents by Inventor Jonathan Wingfield

Jonathan Wingfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180231442
    Abstract: A method and system are provided for detecting the concentration of an analyte in a fluid sample. The method and system involve analysis of a volatilized, ionized fluid sample using a mass spectrometer or other ionic analyte detection device that provides a signal proportional in intensity to the quantity of ionized analyte detected. The improvement involves replacement of a necessary non-analyte component in the fluid sample with a substitute component that serves the same purpose as the original component but is either more volatile than the original component and/or the analyte or undergoes a reaction to provide lower molecular weight reaction products, and results in an increased intensity in signal and signal-to-noise ratio. Acoustic fluid ejection is a preferred method of generating nanoliter-sized droplets of fluid sample that are then volatilized, ionized, and analyzed.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 16, 2018
    Inventors: Richard N. Ellson, Richard G. Stearns, Joseph D. Olechno, Ian Sinclair, Jonathan Wingfield
  • Patent number: 9939352
    Abstract: A method and system are provided for detecting the concentration of an analyte in a fluid sample. The method and system involve analysis of a volatilized, ionized fluid sample using a mass spectrometer or other ionic analyte detection device that provides a signal proportional in intensity to the quantity of ionized analyte detected. The improvement involves replacement of a necessary non-analyte component in the fluid sample with a substitute component that serves the same purpose as the original component but is either more volatile than the original component and/or the analyte or undergoes a reaction to provide lower molecular weight reaction products, and results in an increased intensity in signal and signal-to-noise ratio. Acoustic fluid ejection is a preferred method of generating nanoliter-sized droplets of fluid sample that are then volatilized, ionized, and analyzed.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: April 10, 2018
    Assignee: LABCYTE, INC.
    Inventors: Richard N. Ellson, Richard G. Stearns, Joseph D. Olechno, Ian Sinclair, Jonathan Wingfield
  • Publication number: 20160109336
    Abstract: A method and system are provided for detecting the concentration of an analyte in a fluid sample. The method and system involve analysis of a volatilized, ionized fluid sample using a mass spectrometer or other ionic analyte detection device that provides a signal proportional in intensity to the quantity of ionized analyte detected. The improvement involves replacement of a necessary non-analyte component in the fluid sample with a substitute component that serves the same purpose as the original component but is either more volatile than the original component and/or the analyte or undergoes a reaction to provide lower molecular weight reaction products, and results in an increased intensity in signal and signal-to-noise ratio. Acoustic fluid ejection is a preferred method of generating nanoliter-sized droplets of fluid sample that are then volatilized, ionized, and analyzed.
    Type: Application
    Filed: October 19, 2015
    Publication date: April 21, 2016
    Inventors: Richard N. Ellson, Richard G. Stearns, Joseph D. Olechno, Ian Sinclair, Jonathan Wingfield
  • Patent number: 5908748
    Abstract: An extended species-specific sequence region of yeast transcription factor IIB (yTFIIB) (amino acids 144-157) is critical for cell viability and gene activation. Four residues in yTFIIB, Lys-147, Cys-149, Lys-151, and Glu-152, are critical for yeast cell growth. Intragenic suppressor experiments identified mutations that reversed, or partially reversed, the temperature sensitive phenotype of a yTFIIB derivative bearing amino acid changes at these four positions to human residues. Some of these residues (positions 115, 117 and 182) are located outside the species-specific region of yTFIIB. The identification of this species-specific region provides a unique and specific target for antifungal drugs and a screening assay therefor.
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: June 1, 1999
    Assignee: Children's Hospital Medical Center
    Inventors: Jun Ma, Shruti Shaw, Daniel J. Carson, Michael J. Dorsey, Jonathan Wingfield